Search Tag: Women's Health

IMAGING Management

2024 07 Oct

  Breast cancer remains one of the leading causes of cancer-related mortality among women. Accurate classification of breast cancer subtypes, based on molecular biomarkers such as oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is critical for guiding treatment decisions and predicting outcomes....Read more

Women's Health

2024 07 Oct

  Breast cancer remains one of the leading causes of cancer-related mortality among women. Accurate classification of breast cancer subtypes, based on molecular biomarkers such as oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is critical for guiding treatment decisions and predicting outcomes....Read more

IMAGING Management

2024 02 Oct

  Breast cancer is the most common cancer among women worldwide and remains a significant cause of cancer-related mortality. Traditional diagnostic approaches rely on biopsies and histopathological examinations to determine the prognosis and guide treatment. However, non-invasive imaging techniques, such as Ultrasound-Guided Diffuse Optical Tomography...Read more

Women's Health

2024 02 Oct

  Breast cancer is the most common cancer among women worldwide and remains a significant cause of cancer-related mortality. Traditional diagnostic approaches rely on biopsies and histopathological examinations to determine the prognosis and guide treatment. However, non-invasive imaging techniques, such as Ultrasound-Guided Diffuse Optical Tomography...Read more

Executive Health Management

2024 25 Aug

  Endometriosis, a chronic condition affecting over 1.5 million women and those assigned female at birth in the UK alone, remains underdiagnosed and underfunded despite its significant impact on lives. This disease, which can severely affect education, careers, relationships, fertility, and overall quality of life, is still unknown to many. With...Read more

Women's Health

2024 25 Aug

  Endometriosis, a chronic condition affecting over 1.5 million women and those assigned female at birth in the UK alone, remains underdiagnosed and underfunded despite its significant impact on lives. This disease, which can severely affect education, careers, relationships, fertility, and overall quality of life, is still unknown to many. With...Read more

IMAGING Management

2024 23 Jul

  Congenital cervical malformations (CCMs) are rare and complex deformities of the female lower genital tract. These anomalies arise due to the improper fusion of the Müllerian ducts or failure of subsequent canalisation during embryonic development. The prevalence of CCMs is relatively low, ranging from 1 to 1.25 cases per 100,000 individuals....Read more

Women's Health

2024 23 Jul

  Congenital cervical malformations (CCMs) are rare and complex deformities of the female lower genital tract. These anomalies arise due to the improper fusion of the Müllerian ducts or failure of subsequent canalisation during embryonic development. The prevalence of CCMs is relatively low, ranging from 1 to 1.25 cases per 100,000 individuals....Read more

IMAGING Management

2024 28 May

  Mammography is the main method for breast cancer screening but is less effective for individuals with dense breast tissue, who have a higher risk of cancer. Contrast-enhanced MRI is more sensitive but expensive and time-consuming. An abbreviated MRI (AB-MR) protocol shows promise in maintaining sensitivity while reducing time and cost. Studies...Read more

Women's Health

2024 28 May

  Mammography is the main method for breast cancer screening but is less effective for individuals with dense breast tissue, who have a higher risk of cancer. Contrast-enhanced MRI is more sensitive but expensive and time-consuming. An abbreviated MRI (AB-MR) protocol shows promise in maintaining sensitivity while reducing time and cost. Studies...Read more

IMAGING Management

2024 20 May

  Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced it has signed an agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company.   Established in 2020 to enhance women and children’s health globally through medical advancements, Sonio has developed IT...Read more

Women's Health

2024 20 May

  Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced it has signed an agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company.   Established in 2020 to enhance women and children’s health globally through medical advancements, Sonio has developed IT...Read more

Ultrasound

2024 20 May

  Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced it has signed an agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company.   Established in 2020 to enhance women and children’s health globally through medical advancements, Sonio has developed IT...Read more

IMAGING Management

2024 26 Apr

  Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO   ScreenPoint Medical announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...Read more